Akebia Therapeutics (NASDAQ:AKBA) Stock, Earnings Estimates, EPS, And Revenue

Akebia Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Nov 7
EPS
$-0.100
Quarterly Revenue
$37.4M
Annual Revenue
(as of Sep 30)
$169.9M

Analyze the earnings history of Akebia Therapeutics using advanced sorting and filters.

Data brought to you by Benzinga APIs

Akebia Therapeutics (AKBA) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal Quarter EndDate ReportedActual EPSEstimated EPSSurprise %
Sep 20242024-11-07$-0.10$-0.06-66.7 %
Jun 20242024-08-08$-0.04$-0.0520.0 %
Mar 20242024-05-09$-0.09$-0.08-12.5 %
Dec 20232024-03-14$0$-0.04100.0 %

Akebia Therapeutics (AKBA) Revenue

Quarterly Revenue Surprise Amount

Fiscal Quarter EndDate ReportedActual RevenueEstimated RevenueSurprise %
Sep 20242024-11-07$37.43M$44.51M-15.9 %
Jun 20242024-08-08$43.65M$49.45M-11.7 %
Mar 20242024-05-09$32.61M$46.34M-29.6 %
Dec 20232024-03-14$56.20M$55.39M1.46 %

FAQ

Q

When is Akebia Therapeutics (NASDAQ:AKBA) reporting earnings?

A

Akebia Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 7, 2024 for Q3.

Q

What were the latest earnings per share (EPS) for Akebia Therapeutics (NASDAQ:AKBA)?

A

Akebia Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 7, 2024 for Q3 and the Actual EPS was $-0.10, which missed the estimate of $-0.06.

Q

What were Akebia Therapeutics’s (NASDAQ:AKBA) revenues?

A

Akebia Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 7, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which missed the estimate of {{estEPS}}.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch